Skip to main content
logo
Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.470
+0.170 (7.39%)
At close: Feb 6, 2026, 4:00 PM EST
2.430
-0.040 (-1.62%)
After-hours: Feb 6, 2026, 4:10 PM EST

CNTB Revenue

Connect Biopharma Holdings had revenue of $16.00K in the quarter ending September 30, 2025, a decrease of -98.69%. This brings the company's revenue in the last twelve months to $762.00K, down -96.99% year-over-year. In the year 2024, Connect Biopharma Holdings had annual revenue of $26.03M.

Revenue (ttm)
$762.00K
Revenue Growth
-96.99%
P/S Ratio
167.43
Revenue / Employee
$12,290
Employees
62
Market Cap
138.08M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202426.03M--
Dec 31, 2023---
Dec 31, 2022---
Jan 1, 2022---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sutro Biopharma105.65M
Spero Therapeutics40.55M
Sangamo Therapeutics32.88M
Whitehawk Therapeutics14.38M
NovaBay Pharmaceuticals10.30M
Fate Therapeutics7.14M
Oramed Pharmaceuticals2.00M
Seres Therapeutics351.00K
Revenue Rankings

CNTB News

More News